Showing 351 - 360 of 549 for "Restructuring%20and%20insolvency" with applied filters
29 November 2023 by
2023 At the end of August, there was a shift in real estate control policy.
20 November 2023 by
After the milestone verdict of the Delhi High Court in Allergan v Controller (2023:DHC:515), now it is time for patent strategists to rejoice over landmark judgments of the Madras High Court, including Starpharma Pty Ltd. v Controller (2023/MHC/4638) that provide similar liberal interpretations of amendment of claims under Section 59 of the Patents Act, 1970.
13 November 2023 by
10 November 2023 | New Delhi: Shardul Amarchand Mangaldas advised Ring Plus Aqua Limited (“RPAL”) on the strategic acquisition of 59.25% stake in Maini Precision Products Limited (“MPPL”), an entity engaged in the business of manufacturing
10 October 2023 by
On August 24, 2023, the Ministry of Justice (the “MOJ”) announced partial amendments to the Commercial Act of Korea to bolster regulations on corporate governance and protection of shareholders.
18 September 2023 by
Onshore Transactions Continued their Upward Trend, the Biomedical Sector Remained the Most Popular Investment Destination
15 September 2023 by
From January 2023 to now, AnJie Broad has recruited Mr. Keyu CAO, Mr. Zhining Wang, Mr. Mingqing Zhao, Mr. Kevin TSEN, Ms. Yolanda ZHANG, Ms. Yanyan DENG, Mr. Heng KUANG, Ms. Xueping WEI, Mr. Mark YANG, Mr. Min DING, to join the Firm as partners, and has also internally promoted Ms. Shanshan WU, Ms. Kaiying XU, Ms. Yue MA, Ms. Jingjing CAI, Mr. Xingchao HUANG, Mr. Danyang XIANG to become partners.
05 September 2023 by
Facial recognition technology (“FRT”), an innovation that has garnered both praise and concern, has become increasingly prevalent in our daily lives, from unlocking smartphones to clocking in at work.
11 July 2023 by
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
20 April 2023 by
The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.
27 March 2023 by
Our dedicated series on the P2SK Law continues with our latest Advisory, which explores the changes brought by Chapter V, amending the Capital Market, Money Market, and Forex Market. Following the enactment of the P2SK Law, we can expect many new implementing regulations in the financial sector. Participants in the financial markets should anticipate compliance changes and prepare to quickly adapt to any necessary adjustments.
